average selling prices (ASP)

UG Healthcare remains attractive 'buy' even as target price lowered: RHB - THE EDGE SINGAPORE

Broker's Calls

UG Healthcare remains attractive 'buy' even as target price lowered: RHB

RHB Group Research has maintained its “buy” call on UGHC, but lowered its target price from 95 cents to 75 cents.
RHB sees 'brighter path ahead' for Venture Corp  - THE EDGE SINGAPORE

Broker's Calls

RHB sees 'brighter path ahead' for Venture Corp

RHB Group Research has maintained their “buy” call on Venture Corp and an unchanged target price of $22.60.
×